ARTICLES

1. Pincus SH and Kelbanoff SJ: Quantitative leukocyte iodination. New Eng J Med 284:744-750, 1971.


2. Klebanoff SJ and Pincus SH: Hydrogen peroxide utilization in myeloperoxidase deficient leukocytes: A possible control mechanism. J Clin Invest 50:2226-2229, 1971.


3. Giblett ER, Klebanoff SJ, Pincus SH, Swanson J, Park BH, and McCullough J: Kell phenotypes in chronic granulomatous disease: A potential transfusion hazard. Lancet 1:1235, 1971.


4. Pincus SH, Thomas IT, Clark RA, and Ochs HD: Defective neutrophil chemotaxis with variant ichthyosis hyperimmunoglobulinemia E and recurrent infections. J Ped 87:908-911, 1975.


5. Pincus, SH, Boxer LA, and Stossel TP: Chronic neutropenia in childhood: Analysis of 16 cases and a review of the literature. Am J Med 61:849-861, 1976.


6. Pincus SH: Production of eosinophil-rich guinea pig peritoneal exudates. Blood 52:127-134, 1978.


7. Pincus SH: Comparative metabolism of guinea pig eosinophils and neutrophils. Proc Soc Exp Biol Med 163: 482-489, 1980.


8. Pincus SH: Peroxidase mediated iodination by guinea pig peritoneal exudate eosinophils. Inflamm 4:89-106, 1980.


9. Wolf R, Pincus SH, Rosen F, and Merler E: Diffuse cutaneous lymphoma secreting a potent immunosuppressant. Clin Immunol Immunopathol 18:351-361, 1981.


10. Pincus SH, Butterworth A, David JR, Robbins M, and Vadas M: Antibody-dependent eosinophil mediated damage to schistosomula of Schistosoma mansoni: Lack of requirement for oxidative metabolism. J Immunol 126: 1794-1798, 1981.


11. Pincus SH, DiNapoli AM, Schooley WR, and Broder S: Metabolic heterogeneity among eosinophils from normal and hypereosinophilic patients. Blood 58: 1175-1181, 1981.


12. Kelly RA, Gelfand JA, and Pincus SH: Cutaneous necrosis caused by systemically administered heparin. JAMA 246: 1502-1503, 1981.


13. Pincus SH, DiNapoli AM, and Schooley WR: Superoxide production by eosinophils. Modulation by histamine. J Invest Dermatol 79: 53-57, 1982.


14. Pincus SH: Hydrogen peroxide release from eosinophils: Quantitative comparative studies of human and guinea pig eosinophils. J Invest Dermatol 80: 278-281, 1983.


15. Vadas MA, Varigos G, Nicola N, Pincus SH, Dessein A, Metcalf D, and Battye FL: Eosinophil activation by colony stimulating factor in man: Analysis by flow cytometry. Blood 61: 1232-1242, 1983.


16. Pincus SH, Dessein A, Lenzi H. and David JR: Eosinophil-mediated killing of schistosomula of Schistosoma mansoni: Oxidative requirement for enhancement by eosinophil colony stimulating factor (CSF-alpha) and supernatants with cytotoxicity enhancing activity (E-CEA). Cell Immunol 87: 424-433, 1984.


17. Jacoby W, Cammarata PC, Findlay S, and Pincus SH: Anaphylaxis in mast cell deficient mice. J Invest Dermatol 83: 302-304, 1984.


18. Pincus, SH: Eosinophil-particle interactions. A model system for study of cellular adherence and activation. Cell Immunol 86: 460-471, 1984.


19. Bjornson BB, Pincus SH, DiNapoli AM, and Desforges JA: Inhibition of CFU-NM and CFU-EOS by mature granulocytes. Blood 63: 376-379, 1984.


20. Pincus SH, and Cammarata PC: Eosinophil adherence to muscle larvae of Trichinella spiralis: Quantification and modulation. Immunology 56: 219-225, 1985.


21. Ramesh KS , Pincus SH, and Rocklin R: Human lymphocyte-eosinophil interactions. I. Modulation of phytohemagglutinin-induced lymphocyte proliferation by eosinophils. Cell Immunol 92: 366-375, 1985.


22. Pincus SH: Lectin binding by eosinophils. Proc Soc Exp Bio Med 182: 344-349, 1986.


23. Pincus SH, Cammarata PC, Delima M, and Despommier D: Eosinophilia in murine trichinellosis. J Parasitol 72: 321-325, 1986.


24. Pincus SH, Whitcomb E, and Dinarello CA: Interaction of IL-l and TPA in modulation of eosinophil function. J Immunol 137: 3509-3514, 1986.


25. Ramesh KS , Rocklin R, and Pincus SH: Activated eosinophils synthesize new proteins. Biochem Biophys Acta 923: 241-249, 1987.


26. Kaplan MM, Arora S, and Pincus SH: Primary sclerosing cholangitis. Clinical and histological response to low-dose methotrexate therapy. Ann Intern Med 106: 231235, 1987.


27. Pincus SH, Ramesh KS, and Wyler DJ: Eosinophils stimulate fibroblast DNA synthesis. Blood 70: 572-574, 1987.


28. Ramesh KS , Rocklin R, and Pincus SH: Phosphorylation and dephosphorylation of soluble proteins in human eosinophils. J Cell Biochem 34: 203-211, 1987.


29. Holick MF, Smith E, and Pincus SH: Skin as the site of vitamin D synthesis and target tissue for 1,25-dihydroxyvitamin D3. Arch Dermatol 123: 1677-1683a, 1987.


30. Smith EL, Pincus SH, Donovan L, and Holick MF: A novel approach for the evaluation and treatment of psoriasis: Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasis. J Amer Acad Dermatol 19: 516-528, 1988.


31. Baskar P, and Pincus SH: Eosinophil degranulation: Enhancement in the presence of oxygen. Infect Immun 56: 1907-1911, 1988.


32. Konnikov N, Dinarello CA, and Pincus SH: Elevated plasma interleukin-1 levels in humans following ultraviolet light therapy for psoriasis. J Invest Derm 92: 235-239, 1989.


33. Whitcomb EA, Dinarello CA, and Pincus SH: Effects of IL-1 alpha and IL-1 beta on different subpopulations of human peripheral blood eosinophils. Blood 73: 1904-1908, 1989.


34. Whitcomb EA, Dinarello CA, and Pincus SH: Modulation of eosinophil function by tumor necrosis factor. Int Arch Allergy Appl Immunol 89: 250-255, 1989.


35. Romero L, Ikejima T, and Pincus SH: In situ localization of interleukin 1 in normal and psoriatic skin. J Invest Derm 93: 518-522, 1989.


36. Baskar P, Silberstein D, and Pincus SH: Inhibition of IgG triggered eosinophil function by IL-4. J of Immun. 144: 2321-2326, 1990.


37. Baskar P, and Pincus SH: Eosinophil degranulation: Selective regulation of enzyme release by IL-1 beta. Proc. Soc Exp Bio and Med 199 (2): 249-54, 1992.


38. Kircik LH, Wirth P, Pincus SH: Scars on the legs: Cutaneous fibrosis resulting from intracutaneous injection of cocaine. Arch Dermat 128 (12): 6143-0, 1992.


39. Romero L, Pincus SH: Interleukin 6 in normal skin and atrophic cutaneous disease. Inter Arch Allergy Immun. 99 (1): 44-49, 1992.


40. Conway B, Baskar P, Bechtel LJ, Kaplan JC, Hirsch MS, Schooley RT, Pincus SH: Eosinophils as host cells for HIV-1, Arch Virol 127 (1-4): 373-377, 1992.


41. Wieselthier J, Pincus S: Hailey-Hailey disease of the vulva: A report of 3 cases and review of the literature. Arch Derm 129(10): 1344-1345, 1993.


42. Amster M. Conway J, Zeid M. Pincus S: Cutaneous necrosis secondary to protein S deficiency and increased antiphospholipid antibody in a patient with systemic lupus erythematosus. J Am Acad Derm. 29 (5) part 2, Suppl.: 853-857, 1993.


43. Zellis S, Pincus SH: When the pregnant woman experiences itching. Dermatology Nursing 5:380-383, 1993.


44. Birkland T. Cheavens M. Pincus S: Human eosinophils stimulate DNA synthesis and matrix production in dermal fibroblasts. Arch Derm Res: 286: 312-318, 1994.


45. Pincus S: Women in Academic Dermatology: Results of survey from the professors of dermatology. Arch Derm 130: 1131-1135, 1994.


46. Kircik L, Armus S, Kipping H, and Pincus SH: Eccrine poroma in an unusual location. Cutis 54: 183-184, 1994.


47. Foon K, Vaickus L, Oseroff AR, Russell RN, Bernstein Z, Pincus S. et al: Immune responses in patients with cutaneous T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen. Clin Can Res 1: 1285-1294, 1995.


48. Zellis S, Pincus S: Treatment of vulvar dermatoses. Seminars in Derm 15(1): 71-76, 1996.


49. Guzzo C, Lazarus G, Goffe B, Pincus S. et al: Topical calcipotriene has short term no effect on calcium and bone metabolism of patients with psoriasis. J of Amer Acad Dermatol 34: 429-433, 1996.


50. Mashek H, Licznerski B, Pincus S: Tungiasis in New York. International J of Derm 36: 276-301, 1997.


51. Spellman MC, Pincus SH: Efficacy and safety of azelaic acid and glycolic acid combination therapy compared to tretinoin therapy for acne. Clin Therapeutics 20 (4), 7ll-721, 1998.


52. Lowe NJ , Rizk D, Grimes P, Billips M, and Pincus S: Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients. Clin Therapeutics 20 (5): 945-959, 1998.


53. Christiano AM, Crollick J, Pincus S, and Uitto J: Squamous cell carcinoma in a family with dominant dystrophic epidermolysis bullosa: a molecular genetic. Exp Dermatology 8 (2): 146-152, 1999.


54. Pincus S, Wolff E, and Melander E. The VA National Quality Scholars Fellowship Program: Current Status, Future Directions. Quality Management in Health Care10 (3): 71-76, 2002.


55. Keitz S, Holland G, Melander E, Bosworth H, and Pincus S for the Learners’ Perceptions Working Group. The Veterans Affairs Learners’ Perceptions Survey: The Foundation for Educational Quality Improvement. Academic Medicine 78 (9): 910-917, 2003.


56. Singh D, Holland G, Melander E, Mickey D, and Pincus S. VA's Role in U.S. Health Professions Workforce Planning. Papers and Proceedings of the 13 th Federal Forecasters Conference of 2003 127-133, 2004.


57. Chang BK, Murawsky J, Feldman J, Holland G, Kashner T, Pincus S, and Sanders K. Resident Physicians in VA Outpatient Clinics: Continuity and Advanced Clinic Access Implementation. Fed Pract 24(5):35-54, 2007.

ABSTRACTS

1. Pincus SH and Klebanoff SJ: Quantitative leukocyte iodination. Clin Res 19: 185A, 1971.


2. Stossel TP and Pincus SH: A new macrophage actin-binding protein: Evidence for its role in endocytosis. Clin Res 23: 407A, 1975.


3. Pincus SH and Stossel TP: Macrophage plasma membrane: Association with contractile proteins. Clin Res 24: 109A, 1976.


4. Pincus SH and Smith P: A new model for experimental eosinophil production. Clin Res 25: 100A, 1977.


5. Pincus SH: Comparative metabolism of eosinophils and neutrophils. Clin Res 25: 345A, 1977.


6. Pincus SH: Active eosinophil iodination. Clin Res 26:300A, 1978.


7. Pincus SH: Eosinophil iodination: Regulation by cyclic nucleotides. Clin Res 27:244A, 1979.


8. Pincus SH, Butterworth A, Vadas M, Robbins M, and David JR: Eosinophil specific non-oxidative killing of schistosomula. Clin Res 28:376A, 1980.


9. Pincus SH, DiNapoli AM, Schooley WR, and Broder S: Functional heterogeneity among eosinophils. Clin Res 28:321A, 1980.


10. Pincus SH, Schooley WR, and DiNapoli AM: Eosinophil function modulated by histamine. Clin Res 29:172A, 1981.


11. Pincus SH, Alroy J, and Fallon J: A guinea pig model for hypereosinophilic syndrome. Clin Res 29:171A, 1981.


12. Wyler DJ and Pincus SH: Eosinophils contain fibroblast stimulating factor. Clin Res 29:379A, 1981.


13. Pincus SH, Vadas M. Dessein A, DiNapoli AM, and David JR: Eosinophil helminthotoxicity: Enhancement via an oxidative mechanism. Clin Res 30:376A, 1982.


14. Jacoby W, Pincus SH, Cammarata PC, and Findlay S: Mast cell deficient mice develop immediate hypersensitivity. Clin Res 30:580A, 1982.


15. Pincus SH, DiNapoli AM, and Rocklin R: Oxidative metabolism of eosinophils: Modulation by lymphokine(s). Clin Res 31:350A, 1983.


16. Rocklin R, Kiselis I, and Pincus SH: Modulation of PHA-induced lymphocyte proliferation by human eosinophils (eos). Clin Res 31:540A, 1983.


17. Pincus SH and Mier JM: Modulation of eosinophil helminthotoxicity by lymphocyte-derived factors. Clin Res 32:380A, 1984.


18. Pincus SH, Cammarata PC, Kurtzberg L, Delima M, and Despommier D: Eosinophilia in murine trichinosis. 6 th Int Conf on Trichinellosis, McGill Univ., 1985.


19. Pincus SH, Whitcomb E, Rocklin R, and Dinarello CA: Interleukin 1 enhances eosinophil function. Clin Res 33:385A, 1985.


20. Ramesh KS , Pincus SH, and Rocklin R: Characterization of a lymphocyte inhibitory factor derived from activated eosinophils. Clin Res 33:386A, 1985.


21. Konnikov N, Dinarello CA, and Pincus SH: UVB therapy increases interleukin-1 (IL-1) in vivo. Clin Res 39:760A, 1986.


22. Pincus SH, Whitcomb EA, and Dinarello CA: Interleukin-1 (IL-1) increases lymphocyte intracellular Ca++. Clin Res 39:503A, 1986.


23. Pincus SH, Whitcomb EA, and Dinarello CA: Interaction of interleukin-1 (IL-1) and PMA in modulation of eosinophil function: Implications for IL-1 mechanism of action. Lymphokine Res 6:1208, 1987.


24. Konnikov N, Dinarello CA, and Pincus SH: Ultraviolet B (UVB) therapy increases human plasma interleukin-1 (IL-1) levels. Lymphokine Res 6:1209, 1987.


25. Holick, MF, Smith EL, and Pincus SH: A new approach for the treatment of psoriasis: Topical or oral use of 1,25-dihydroxyvitamin D3 may be a safe and effective therapy for psoriasis. Clin Res 35(3):581A, 1987.


26. Konnikov N, Ree HJ, Dinarello CA, and Pincus SH: Interleukin-1 (IL-1) is present in psoriatic plaques. Clin Res 35(3):696A, 1987.


27. Romero L, Pincus SH: Interleukin-6 is increased in atrophic cutaneous disease. Clin Res 37(2):694A, 1989.


28. Birkland T, Cheavens M, Pincus SH: Human eosinophils stimulate fibroblast growth. Clin Res 39(3):675A, 1991.


29. Goldman B, Fujihara K, Bisaccia E, Pincus S, Greenberg SJ, and Oseroff AR: HTLV retroviral homologous sequences in mycosis fungoides/Sezary syndrome. J Invest Dermatol 98:660A, 1992.


30. Birkland T, Cheavens M, Pincus SH: Human eosinophils stimulate fibroblast growth. Clin Res 40(2):465A, 1992.


31. Birkland T, Oseroff A, Pincus S: Human eosinophils (EOS) are cytotoxic to a carcinoma cell line. Clin Res 4(3):669A, 1992.


32. Wehr R, Gibson J, Epinette W, Chesnut C, Goffe B, Katz I, Fridley MN, Lazarus G, Lowe N, Pincus S: The safety of topically applied calcipotriene ointment 0.005% (a vitamin D 2 analogue) as measured by blood, urine and bone density analysis in psoriatic patients. Skin Pharm Soc Proc., 1993.


33. Birkland T, Solecki D, Oseroff A, Pincus S: Tumor cell cytotoxicity is mediated by human eosinophils (EOS). Clin Res 41(2):468A, 1993.


34. Oseroff AR, Chatterjee M, Russell D, Vaikus L, Pincus SH, Stoll H, Beers TF, Kohler H, Foon KA: Monoclonal anti-idiotype vaccine therapy for cutaneous T cell lymphoma. J Invest Derm 101:414A, 1993.


35. Birkland TP, Solecki D, Oseroff AR, Pincus SH: Cytokine modulation of eosinophil-mediated cytotoxicity. Clin Res 41:609A, 1993.


36. Pincus S, Oseroff A, Breneman D, Foss F. Koh H, Duvic M. Vonderheid EC, Coe B, Phillips SB, Bernstein JE: Effectiveness of topical Naloxone HCL, 0.05%, in the treatment of pruritus associated with mycosis fungoides (MF) and Sezary syndrome (SS). J Invest Derm 104:661, 1995.


37. Spellman MC, Piacquadio DJ, Pincus S: Azelaic acid and glycolic acid combination for mild to moderate acne. Am Acad of Derm meeting, 1998.


38. Lowe NJ , Grimes P, Pincus S, d Harper H: Efficacy and safety of azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker skinned patients. Am Acad of Derm meeting, 1998.


39. Pincus S, Holland G, Keitz S, Aron D, Cannon G: Learners’ Perceptions of Clinical Training Experience in Veterans Affairs Medical Centers. Scientific Poster Presentation for Innovations in Medical Education Section. Society of General Internal Medicine annual meeting, 2002.


40. Keitz S, Holland G, Aron D, Cannon G, Pincus S: Learners’ Perceptions of Physician Resident Training Experience in Veterans Affairs (VA) Medical Centers. Scientific Poster Presentation. Assoc of Am Med Colleges annual meeting, 2002.


41. Holland G, Aron D, Cannon G, Gilman S, Graber M, Kaminetzky C, Keitz S, Melander E, Mickey D, Pincus S: National Physician Resident Learners’ Perceptions Survey. Exhibit Presentation. 2002 Innovations in Medical Education (IME) Exhibit at the Assoc of Am Med Colleges annual meeting, 2002.


42. Buchanan R, Holland G, Melander E, Mickey D, Pincus S: Learners’ Perceptions of Dental Trainees in VA and non-VA Institutions. Exhibit Presentation. American Dental Education Association annual meeting, 2002.


43. Pincus, SH: Women in the Physician Workforce: Can the United States Learn from International Experiences? Poster Presentation. Assoc of Am Med Colleges Physician Workforce Research Conference, May 2005.


44. Pincus SH: Women In The Physician Workforce: Implications For Workforce Planning, Women in the International Physician Workforce. Presentation at the Assoc of Am Medical Colleges Physician Workforce Research Conference, May 2005.


45. Kashner TM, Chang BK, Holland GJ, Hinson RS, Melander E, Mickey D, Kashner T, Sanders KM, Pincus SH. Do Residents Contribute to Clinical Care. Presentation at the Assoc of Am Medical Colleges Physician Workforce Research Conference, May 2005.

BOOK CHAPTERS

1. Pincus SH. Dermatology. In Proger S and Barza M (eds): Diagnostic Imperatives. Thieme Stratton, Inc., New York , 1981.


2. Pincus SH. Dermatologic Care of the Surgical Patient. In Molitch M (ed): Management of Medical Problems in Surgical patients. 3 rd Ed. F.A. David Pub. Co., Philadelphia , 1982.


3. Pincus SH and Wolff SM. Eosinophilic Diseases of the Skin. In Austen KF and Fitzpatrick TB (eds): Update I: Dermatology in General Medicine, McGraw Hill, 1983.


4. Pincus SH. Contact Dermatitis. In Kagan B and Gellis S (eds): Current Pediatric Therapy. W.B. Saunders Co., 1984.


5. Pincus SH. The Eosinophil. In Stone JF (ed): Dermatologic Allergy and Immunology. C.V. Mosby Co., 1985.


6. Pincus SH. Cutaneous Eosinophilic Diseases. In Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, and Austen KF (eds): Dermatology in General Medicine. Third Ed. McGraw Hill, 1986.


7. Pincus SH. Diseases of the Female Genitalia. In Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, and Austen KF (eds): Dermatology in General Medicine. Third Ed. McGraw Hill, 1986.


8. Pincus SH, Stadecker MJ. Vulvar Dystrophies and Non-Infectious Inflammatory Conditions. In Wilkinson EJ (ed): Pathology of the vulva and vagina. New York : Churchill Livingstone Inc, 1987.


9. Rocklin R, Pincus SH. Atopic Dermatitis. In Austen KF, Samter M, Talmage D, Claman H, and Frank M (eds): Immunological Diseases. Fourth Ed. Little, Brown & Co. , 1988.


10. Pincus SH. Vulvar Dermatoses and Pruritus Vulvae in Dermatologic Clinics. Turner MLC and Marinoff (eds): W. B. Saunders Company, 10(2):297-308, 1992.


11. Pincus SH, McKay M. Disorders of the Anogenitalia of Females. In Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg I , and Austen KF (eds): Dermatology in General Medicine. Fourth Ed. 113(1):1463-1481, McGraw Hill, 1993.


12. Holbrook KA, Pincus S, Parker F, Holloway Jr. GA, Kraning KB, Yancey K, and Lawley TJ. Structure, Function, and Immunology of the Skin. In Middleton Jr. E, Reed CE, Ellis EF, Adkinson Jr. NF, Yunginger JW, and Busse WW (eds): ALLERGY: Principles and Practice, Fourth Ed, Vol 1, Mosby Year Book, Inc., 1993.


13. Shanler SD, Zellis SL, Oseroff AR, and Pincus SH. Application of the Polymerase Chain Reaction to the Diagnoses of Infectious Diseases of the Skin. In Erlich GD and Greenberg SJ (eds): PCR-Based Clinical Diagnostics. Blackwell Scientific Publications, Inc., 1994.


14. Pincus SH, Shah F. Classification and Treatment of Inflammatory Diseases of Pregnancy. In Dahl MV and Lynch PJ (eds): In Current Opinion in Dermatology, Second Edition, Current Science, 1995.


15. Pincus S, Zellis S. Miscellaneous Agents-Vitamin D (calcipotriol). In McDonald C (ed): Immunomodulatory and Cytoxic Agents in Dermatology. Marcel Dekker, Inc., 157-167, 1996.